SBSS_Notice_-_Cidofovir.pdf

Small Business Sources Sought Notice Page 1 of 4

Small Business Sources Sought Notice

HHS-ASPR-SBSS-75A50119R00042

DESCRIPTION

This is a Small Business Sources Sought Notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding:

(1) the availability and capability of qualified small business sources; (2) whether they are small businesses; HUBZone small business; woman-owned small business; or small disadvantaged business; and (3) their size classification relative to the North American Industry Classification

System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice.

BACKGROUND

The mission of the Division of Strategic National Stockpile (DSNS) is to deliver critical medical assets to the site of a national emergency. In 2001, the recommendations for the use of smallpox

(vaccinia) vaccine by the Advisory Committee on Immunization Practices (ACIP) were updated to include the use of vaccinia vaccine in the event that smallpox (Variola) virus is used as an agent of biological terrorism or for some other unforeseen reason, a smallpox outbreak were to occur. Adverse reactions may occur in individuals who receive the vaccinia vaccine. The adverse reactions may range from mild and self-limited to severe and life-threating. With the continued availability of the smallpox vaccinia vaccine, the Office of the Assistant Secretary for

Preparedness and Response (ASPR), DSNS requires Cidofovir 375mg/5ml, injection single dose vials as a second-line agent for the treatment of certain vaccine-associated, severe adverse reactions.

PURPOSE AND OBJECTIVES

The purpose of this acquisition is to acquire and deliver Cidofovir 375mg/5ml injection single dose vials to the DSNS in accordance with the delivery schedule outlined below.

PROJECT REQUIREMENTS

The contractor shall provide and ship requested amount of Cidofovir (Vistide) injection 375mg/5ml, 5ml single dose vials to DSNS receiving facilities. DSNS will provide ship to addresses and required quantities to each address upon award.

Shipping Requirements:

At the time of delivery to the Government, the Contractor is required to provide no less than 24 months of shelf life dating.

No Partial Case or Packages quantities will be accepted.

No Mixed Lot #'s per Case or per Packages will be accepted.

One Lot number per pallet. The last pallet will be able to contain multiple lot numbers per pallet PO; Lots must be clearly identified.

Small Business Sources Sought Notice Page 2 of 4

Lot numbers and quantities shall be included on the packing list.

All pallets are to have the identical TyHi stack pattern except for the last final pallet.

All product to be delivered on standard 48" by 40" pallet, not to exceed 60” in height, stretch wrapped and secured to pallet for safe transport.

Contractor shall contact designated POC to schedule delivery appointments.

PLEASE REQUEST VENDOR TO PLACE STORAGE REQUIREMENTS ON

ALL PACKING LISTS****

DELIVERABLES/REPORTING SCHEDULE

Item Description Quantity Completion Date

BASE Yr

CLIN 0001

CLIN 0002

Cidofovir (Vistide) injection

375mg/5ml, 5ml single dose

750 VI

Deliver NLT 30 Sep 2019

750 VI to

OPT Yr 1

CLIN 0003

CLIN 0004

1,000 VI

Deliver 30 Sep 30 Sep 2020

1,000 VI to

OPT Yr 2

Deliver (T.B.D. by Expiring stock)

CLIN 0005

CLIN 0006

OPT Yr 3

CLIN 0007

CLIN 0008

Small Business Sources Sought Notice Page 3 of 4

OPT Yr 4

CLIN 0009

CLIN 0010

OTHER IMPORTANT CONSIDERATIONS

The North American Industry Classification System (NAICS) Code is 325412 with a size standard of 1,250 employees.

CAPABILITY STATEMENT

The capability statement should include 1) the total number of employees, 2) documentation of ability to provide the required equipment, 3) any contractor GSA Schedule contracts by which all of the requirements may be met, if applicable, and 4) any other information considered relevant to this program. Contractors must also provide their Company Name, DUNS number, Physical

Address, and Point of Contact Information.

Interested small business organizations are required to identify their size standards in accordance with the Small Business Administration. The government requests that no proprietary or confidential business data be submitted in a response to this notice. However, responses that indicate the information therein is proprietary will be properly safeguarded for Government use only. Capability statements must include the name and telephone numbers of a point of contact having authority and knowledge to discuss responses with Government representatives.

Capability statements in response to this market survey that do not provide sufficient information for evaluation will be considered non-responsive. When submitting this information, please reference the solicitation notice number.

All capability statements sent in response to this Sources Sought Notice must be submitted to

Heather Orandi, Contract Specialist, via email at Heather.Orandi@hhs.gov before the closing date and time of this announcement. All responses must be received by the specified due date and time in order to be considered.

DISCLAIMER AND IMPORTANT NOTES:

This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work.

Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a combined synopsis solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation.

CONFIDENTIALITY

mailto:Heather.Orandi@hhs.gov

Small Business Sources Sought Notice Page 4 of 4

No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).